Masimo Corp. (MASI)
141.28
+1.51
(+1.08%)
USD |
NASDAQ |
Dec 11, 16:00
141.31
+0.03
(+0.02%)
After-Hours: 20:00
Masimo Research and Development Expense (Quarterly): 30.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 20.42M |
| West Pharmaceutical Services, Inc. | 17.10M |
| Insulet Corp. | 77.20M |
| UFP Technologies, Inc. | -- |
| Clearpoint Neuro, Inc. | 3.452M |